Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Gross Profit: 2019-2025

Historic Gross Profit for Neurogene (NGNE) over the last 3 years, with Sep 2025 value amounting to -$42,000.

  • Neurogene's Gross Profit fell 121.05% to -$42,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$610,000, marking a year-over-year increase of 47.91%. This contributed to the annual value of $925,000 for FY2024, which is 3403.57% up from last year.
  • Neurogene's Gross Profit amounted to -$42,000 in Q3 2025, which was up 43.24% from -$74,000 recorded in Q2 2025.
  • Neurogene's 5-year Gross Profit high stood at -$3,000 for Q1 2023, and its period low was -$602,000 during Q1 2024.
  • Moreover, its 3-year median value for Gross Profit was -$42,000 (2025), whereas its average is -$162,909.
  • Its Gross Profit has fluctuated over the past 5 years, first slumped by 19,966.67% in 2024, then soared by 86.71% in 2025.
  • Over the past 3 years, Neurogene's Gross Profit (Quarterly) stood at -$17,000 in 2023, then plummeted by 2,335.29% to -$414,000 in 2024, then plummeted by 121.05% to -$42,000 in 2025.
  • Its last three reported values are -$42,000 in Q3 2025, -$74,000 for Q2 2025, and -$80,000 during Q1 2025.